Abdul Mannan: How SSRIs Might Affect Platelet Function
Abdul Mannan, Consultant Hematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn:
“Your SSRI might be affecting how your platelets work.
Most people don’t know this.
Most doctors don’t talk about it.
But the biology is real.
Here’s what’s happening:
- Platelets don’t make serotonin. They absorb it from blood and store it. This stored serotonin helps activate platelets during clotting.
- SSRIs block the serotonin transporter (SERT). Over time, platelets may have less serotonin available.
- The SLC6A4 gene controls how active your SERT is. Some people carry the high-activity L(A)/L(A) genotype. Others have lower-activity types: S or L(G).
- In studies, patients with lower-activity genotypes (fewer than 2 L(A) alleles) showed longer PFA-100 closure times and prolonged bleeding times by about 2.3 minutes on SSRIs.
- In high-activity genotypes, SSRIs caused little or no change in bleeding time.
So genetics may modulate how much your platelets are affected by these drugs.
But before you order a gene panel – the clinical message is more grounded than that.
- The biology is plausible.
- The evidence is small and mixed.
- Not all studies agree.
- Routine genetic testing is not currently recommended.
The bigger bleeding risks remain age, aspirin and NSAID use, anticoagulants, and prior GI bleeding.
This is a conversation worth having with patients on SSRIs who also have other bleeding risk factors.
Have you seen unexpected bleeding in a patient on SSRIs?
How did you approach it?”
More posts featuring Abdul Mannan on Hemostasis Today.
-
Jul 3, 2026, 14:55Rabiah Alnoshan: The Importance of Pulse Examination in Acute Limb Ischemia
-
Jul 3, 2026, 14:44Carrie Gillies: Personal Experience Reinforces the Need for Timely DVT Diagnosis
-
Jul 3, 2026, 14:30Munazza Sikandar: Comparing Figure-of-Eight Sutures and Manual Compression for Safer Post-Ablation Care
-
Jul 3, 2026, 14:20Stefano Navarro: Partial GPVI Downregulation Shows Promise for Safer Antithrombotic Therapy
-
Jul 3, 2026, 13:31Javed Anees: TIA is a Medical Emergency – Not a Benign Warning
-
Jul 3, 2026, 12:46Heghine Khachatryan: 2026 AHA Guideline on the Management of CKM Syndrome
-
Jul 3, 2026, 12:32Shadi Tabibian: Beyond Bleeding – Women Living with von Willebrand Disease
-
Jul 3, 2026, 09:33Abdul Mannan: Not All Type 1 VWD Starts in the VWF Gene
-
Jul 3, 2026, 09:18Aryabhatta Sadhu: Sickle Cell Crisis – When Diagnostics Should Change Therapy